Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Nucleic Acids Research|March 24, 2010
Synthesis of high-quality libraries of long (150mer) oligonucleotides by a novel depurination controlled processEmily M LeProust, Bill J Peck, Konstantin Spirin, et al.
Nucleic Acid Therapeutics|May 8, 2024
Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer OrganoidsLedong Wan, Alexander J Kral, Dillon Voss, et al.
International Journal of Molecular Sciences|August 10, 2024
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral SclerosisRita Mejzini, Marvin H Caruthers, Balazs Schafer, et al.
Cell Discovery|April 20, 2026
ASO-based PKM splice-switching therapy increases anti-CTLA-4 antibody efficacy in pancreatic ductal adenocarcinomaLijie Han, Lina Gan, Balázs Schäfer, et al.
Nature Communications|June 4, 2021
Nuclear compartmentalization of TERT mRNA and TUG1 lncRNA is driven by intron retentionGabrijela Dumbović, Ulrich Braunschweig, Heera K Langner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 4, 2026
Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutationPoulami Banik, Felix Zimmann, Prasoon K Thakur, et al.
Journal of the American Chemical Society|June 22, 2011
Streamlined process for the chemical synthesis of RNA using 2'-O-thionocarbamate-protected nucleoside phosphoramidites in the solid phaseDouglas J Dellinger, Zoltán Timár, Joel Myerson, et al.
The Journal of Biological Chemistry|February 24, 2025
PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinomaDillon M Voss, Alexander J Kral, GeunYoung Sim, et al.
Cell Reports|June 14, 2023
Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expressionAmy E Campbell, Michael C Dyle, Roberto Albanese, et al.
Experimental Hematology & Oncology|June 10, 2026
Multifactorial effects of LGALS1 blockade sensitize tumors to immune checkpoint inhibitorJessy John, Mohammad A I Al-Hatamleh, Monika Vashisht, et al.
Pageof 4